Welcome to the website of the PAOLA-1 study

Randomized, Double-Blind, Phase III Trial Olaparib vs. Placebo in Patients with Advanced
FIGO Stage IIIB - IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or
Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane
Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance
  • ARCAGY RESEARCH
  • Phone : +33 1 42 34 83 23
  • Fax: +33 1 43 26 26 73
  • Email: paola-1@arcagy.org
  • ASCOpharm Gr Novasco
  • Phone : +33 1 56 33 35 51
  • Fax: +33 1 56 33 35 50
  • Email: s.brutto@novasco.fr